Bfsg LLC purchased a new stake in shares of BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 2,741 shares of the company’s stock, valued at approximately $41,000.
A number of other institutional investors have also bought and sold shares of the company. Camelot Portfolios LLC boosted its position in BlackRock Capital Allocation Term Trust by 4.3% during the fourth quarter. Camelot Portfolios LLC now owns 24,500 shares of the company’s stock valued at $366,000 after acquiring an additional 1,000 shares during the last quarter. Raymond James Financial Services Advisors Inc. boosted its position in BlackRock Capital Allocation Term Trust by 6.8% during the third quarter. Raymond James Financial Services Advisors Inc. now owns 25,074 shares of the company’s stock valued at $363,000 after acquiring an additional 1,589 shares during the last quarter. Claro Advisors LLC boosted its position in BlackRock Capital Allocation Term Trust by 9.9% during the fourth quarter. Claro Advisors LLC now owns 17,736 shares of the company’s stock valued at $265,000 after acquiring an additional 1,603 shares during the last quarter. Sugarloaf Wealth Management LLC bought a new stake in BlackRock Capital Allocation Term Trust during the fourth quarter valued at $25,000. Finally, Consolidated Portfolio Review Corp boosted its position in BlackRock Capital Allocation Term Trust by 2.3% during the fourth quarter. Consolidated Portfolio Review Corp now owns 89,622 shares of the company’s stock valued at $1,340,000 after acquiring an additional 2,017 shares during the last quarter. Institutional investors own 36.12% of the company’s stock.
Insider Activity
In related news, major shareholder Saba Capital Management, L.P. acquired 8,476 shares of the company’s stock in a transaction dated Monday, February 5th. The shares were purchased at an average price of $15.40 per share, for a total transaction of $130,530.40. Following the completion of the acquisition, the insider now owns 14,476,448 shares of the company’s stock, valued at $222,937,299.20. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Over the last 90 days, insiders have purchased 1,568,050 shares of company stock worth $24,609,178.
BlackRock Capital Allocation Term Trust Stock Down 0.3 %
BlackRock Capital Allocation Term Trust Announces Dividend
The business also recently disclosed a monthly dividend, which will be paid on Tuesday, April 30th. Stockholders of record on Monday, April 15th will be issued a dividend of $0.127 per share. The ex-dividend date of this dividend is Friday, April 12th. This represents a $1.52 annualized dividend and a dividend yield of 9.90%.
BlackRock Capital Allocation Term Trust Profile
–
Featured Articles
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Buy P&G Now, Before It Sets A New All-Time High
- Alphabet Changes the Narrative with Its First-Ever Dividend
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- 5 High-Yielding Oversold Stocks with Bullish Ratings
Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report).
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.